Randomized controlled trials (RCTs) of moxibustion in the treatment of allergic rhinitis, with no publication year and no language restriction. Participants: Patients with allergic rhinitis who met accepted diagnostic criteria, such as Guidelines for diagnosis and Treatment of Allergic rhinitis (2015, Tianjin)[22 ] or Allergic Rhinitis and its Impact on Asthma (ARIA) 2008[23 (link)] or Chinese society of allergy guidelines for the diagnosis and treatment of allergic rhinitis.[24 (link)] Aged over 18 years old. Without race, sex, course of disease or region restriction. Interventions and Comparisons: The intervention methods of observation group were moxibustion related therapy, or moxibustion combined with other traditional Chinese medicine therapies. The intervention methods of the control group included Placebo or blank control, Conventional western medicine treatment, or the comparison between different moxibustion intervention measures. Definition table of different moxibustion therapies is in the Supplementary File Table S2, Supplemental Digital Content, http://links.lww.com/MD/I502. Outcomes: Primary outcome: the clinical effective rate. Secondary outcomes: rhino-conjunctivitis quality of questionnaire (RQLQ) scores,[25 (link),26 (link)] the level of immunoglobulin E (IgE), visual analog scale (VAS) scores.[27 (link)]
Free full text: Click here